Vimarsana
Biggest News Aggregation in the World

Conor Steuer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Conor Steuer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Conor Steuer Today - Breaking & Trending Today

Vaccinex : ASCO Conference Presentation - MarketScreener - Vimarsana News

Vaccinex : ASCO Conference Presentation - MarketScreener

Correlative and spatial biomarker analysis of a phase 1/2b study to evaluate PEPINEMAB IN COMBINATION WITH PEMBROLIZUMAB for first-linetreatment...

Treatment Landscape of ALK-positive Metastatic NSCLC: A Stakeholder Interchange Report - Vimarsana News

Treatment Landscape of ALK-positive Metastatic NSCLC: A Stakeholder Interchange Report

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.

Source: ajmc.com
Research roundup: Recent grants and publications for Emory faculty and staff - Vimarsana News

Research roundup: Recent grants and publications for Emory faculty and staff

Rollins receives $6 million grant from Gilead’s HIV initiative Emory’s Rollins School of Public Health has announced a $6 million grant from Gilead Sciences, Inc. over three years to continue to build the capacity of organizations working on the frontlines of the HIV crisis in communities across the Southern United States. Emory will serve as one of four Gilead COMPASS coordinating centers alongside the Southern AIDS Coalition, the University of Houston Graduate College of Social Work, and Wake Forest School of Divinity to provide direct support to local community organizations to help mi...

Source: emory.edu
Study: High Rate of Smoking Reduction, Cessation in Patients With Lung Cancer Following Study Entry - Vimarsana News

Study: High Rate of Smoking Reduction, Cessation in Patients With Lung Cancer Following Study Entry

A recent comprehensive, prospective study of smoking habits among patients with non-small cell lung cancer demonstrated a high rate of smoking reduction and cessation following entry into the phase 3 early-stage trial.

Patients with lung cancer reduce smoking rate after enrollment in phase III clinical trial - Vimarsana News

Patients with lung cancer reduce smoking rate after enrollment in phase III clinical trial

 E-Mail (DENVER--February 1, 2021, 10:00 a.m. EST) The first comprehensive, prospective study of smoking habits in patients with non-small cell lung cancer (NSCLC) who were enrolled in a phase III early-stage trial revealed that there was a high rate of smoking reduction and cessation following study entry, according to research published today in the Journal of Thoracic Oncology. The JTO is the official journal of the International Association for the Study of Lung Cancer. Continued smoking after a lung cancer diagnosis is associated with an approximate 50% median increase in mortality , ...